An expanded concept of "insurance" supplementation--broad-spectrum protection from cardiovascular disease.
The preventive merits of "nutritional insurance" supplementation can be considerably broadened if meaningful doses of nutrients such as mitochondrial "metavitamins" (coenzyme Q, lipoic acid, carnitine), lipotropes, and key essential fatty acids, are included in insurance supplements. From the standpoint of cardiovascular protection, these nutrients, as well as magnesium, selenium, and GTF-chromium, appear to have particular value. Sophisticated insurance supplementation would likely have a favorable impact on many parameters which govern cardiovascular risk--serum lipid profiles, blood pressure, platelet stability, glucose tolerance, bioenergetics, action potential regulation--and as a life-long preventive health strategy might confer substantial benefit.
D000959:Antihypertensive Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001792:Blood Platelets / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy*; D004734:Energy Metabolism / Q000187:drug effects; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008082:Lipotropic Agents / Q000627:therapeutic use; D008274:Magnesium / Q000627:therapeutic use; D013654:Taurine / Q000627:therapeutic use
D000959:Antihypertensive Agents; D000960:Hypolipidemic Agents; D008082:Lipotropic Agents; D013654:Taurine; D008274:Magnesium